The TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, can inhibit tumor cell growth by initiating apoptotic pathways in many types of solid and hematologic cancers, while without affecting normal cells [7,8]. Here, TNFSF10 is linked to hematopoietic and lymphoid cell neoplasm.